Skip to Content

Notice

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Division of Microbiology & Infectious Diseases: Regulatory Affairs Support.

Date: November 17-18, 2014.

Time: November 17, 2014, 8:30 a.m. to 5:00 p.m.

Agenda: To review and evaluate contract proposals.

Place: Hilton Washington/Rockville, Jackson Room, 1750 Rockville Pike, Rockville, MD 20852, (Telephone Conference Call).

Time: November 18, 2014, 8:30 a.m. to 2:00 p.m.

Agenda: To review and evaluate contract proposals.

Place: Hilton Washington/Rockville, Jackson Room, 1750 Rockville Pike, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Richard W. Morris, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fisher Lane-5601FL, Rockville, Maryland 20892-9823, Mailstop 9823, Telephone-240-669-5022, Fax: 301-480-2408.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Start Signature

Dated: October 7, 2014.

David Clary,

Program Analyst, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 2014-24385 Filed 10-14-14; 8:45 am]

BILLING CODE 4140-01-P